<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="MEDLINE" Owner="NLM">        <PMID Version="1">30097015</PMID>        <DateCompleted>            <Year>2018</Year>            <Month>08</Month>            <Day>17</Day>        </DateCompleted>        <DateRevised>            <Year>2018</Year>            <Month>08</Month>            <Day>17</Day>        </DateRevised>        <Article PubModel="Electronic">            <Journal>                <ISSN IssnType="Electronic">0717-6287</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>51</Volume>                    <Issue>1</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Aug</Month>                        <Day>10</Day>                    </PubDate>                </JournalIssue>                <Title>Biological research</Title>                <ISOAbbreviation>Biol. Res.</ISOAbbreviation>            </Journal>            <ArticleTitle>Knockdown of PAICS inhibits malignant proliferation of human breast cancer cell lines.</ArticleTitle>            <Pagination>                <MedlinePgn>24</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1186/s40659-018-0172-9</ELocationID>            <Abstract>                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase (PAICS), an enzyme required for de novo purine biosynthesis, is associated with and involved in tumorigenesis. This study aimed to evaluate the role of PAICS in human breast cancer, which remains the most frequently diagnosed cancer and the leading cause of cancer-related death among women in less developed countries.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Lentivirus-based short hairpin RNA targeting PAICS specifically depleted its endogenous expression in ZR-75-30 and MDA-MB-231 breast cancer cells. Depletion of PAICS led to a significant decrease in cell viability and proliferation. To ascertain the mechanisms through which PAICS modulates cell proliferation, flow cytometry was performed, and it was confirmed that G1-S transition was blocked in ZR-75-30 cells through PAICS knockdown. This might have occurred partly through the suppression of Cyclin E and the upregulation of Cyclin D1, P21, and CDK4. Moreover, PAICS knockdown obviously promoted cell apoptosis in ZR-75-30 cells through the activation of PARP and caspase 3 and downregulation of Bcl-2 and Bcl-xl expression in ZR-75-30 cells.</AbstractText>                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">These findings demonstrate that PAICS plays an essential role in breast cancer proliferation in vitro, which provides a new opportunity for discovering and identifying novel effective treatment strategies.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Meng</LastName>                    <ForeName>Minjun</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Breast Surgery, The Affiliated Zhongshan Hospital of Xiamen University, No. 201, Hubin South Road, Xiamen, 361000, Fujian, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Chen</LastName>                    <ForeName>Yanling</ForeName>                    <Initials>Y</Initials>                    <AffiliationInfo>                        <Affiliation>Xiamen Siming District Kaiyuan Street Community Health Service Center, Xiamen, 361000, Fujian, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Jia</LastName>                    <ForeName>Jianbo</ForeName>                    <Initials>J</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Breast Surgery, The Affiliated Zhongshan Hospital of Xiamen University, No. 201, Hubin South Road, Xiamen, 361000, Fujian, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Li</LastName>                    <ForeName>Lianghui</ForeName>                    <Initials>L</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Breast Surgery, The Affiliated Zhongshan Hospital of Xiamen University, No. 201, Hubin South Road, Xiamen, 361000, Fujian, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Yang</LastName>                    <ForeName>Sumei</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Breast Surgery, The Affiliated Zhongshan Hospital of Xiamen University, No. 201, Hubin South Road, Xiamen, 361000, Fujian, China. sumei_yang@yeah.net.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>08</Month>                <Day>10</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>England</Country>            <MedlineTA>Biol Res</MedlineTA>            <NlmUniqueID>9308271</NlmUniqueID>            <ISSNLinking>0716-9760</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D014408">Biomarkers, Tumor</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>EC 4.1.1.-</RegistryNumber>                <NameOfSubstance UI="D002262">Carboxy-Lyases</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>EC 4.1.1.21</RegistryNumber>                <NameOfSubstance UI="C022378">phosphoribosylaminoimidazole carboxylase</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>EC 6.3.2.-</RegistryNumber>                <NameOfSubstance UI="D010453">Peptide Synthases</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>EC 6.3.2.6</RegistryNumber>                <NameOfSubstance UI="C022379">phosphoribosylaminoimidazole-succinocarboxamide synthetase</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2017 Mar 15;8(13):20572-20587</RefSource>                <PMID Version="1">28411283</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Epidemiol. 2014 Oct;38(5):465-70</RefSource>                <PMID Version="1">25182670</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Exp Cell Res. 1997 Oct 10;236(1):173-80</RefSource>                <PMID Version="1">9344597</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Anim Genet. 2004 Dec;35(6):438-44</RefSource>                <PMID Version="1">15566465</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Mol Biol. 2007 Mar 9;366(5):1603-14</RefSource>                <PMID Version="1">17224163</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Annu Rev Med. 2014;65:95-110</RefSource>                <PMID Version="1">24422569</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>CA Cancer J Clin. 2015 Mar;65(2):87-108</RefSource>                <PMID Version="1">25651787</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell. 1997 Nov 14;91(4):443-6</RefSource>                <PMID Version="1">9390553</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Expert Opin Pharmacother. 2014 Jun;15(9):1277-88</RefSource>                <PMID Version="1">24787047</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>CA Cancer J Clin. 2015 Jan-Feb;65(1):5-29</RefSource>                <PMID Version="1">25559415</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2013 May 21;8(5):e63597</RefSource>                <PMID Version="1">23704925</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2013 May 22;8(5):e64873</RefSource>                <PMID Version="1">23717670</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet. 2011 Oct 22;378(9801):1461-84</RefSource>                <PMID Version="1">21924486</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Adv Clin Chem. 2014;63:123-67</RefSource>                <PMID Version="1">24783353</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>N Engl J Med. 2005 Oct 27;353(17):1784-92</RefSource>                <PMID Version="1">16251534</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 1999 Apr 1;59(7):1492-7</RefSource>                <PMID Version="1">10197619</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Med Genomics. 2011 Jun 07;4:49</RefSource>                <PMID Version="1">21649900</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Curr Pharm Des. 2003;9(31):2593-613</RefSource>                <PMID Version="1">14529544</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cancer. 2008 Nov 06;7:83</RefSource>                <PMID Version="1">18990230</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Oncol (R Coll Radiol). 2013 Feb;25(2):117-26</RefSource>                <PMID Version="1">23219233</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Histochem Cytochem. 2009 Apr;57(4):289-300</RefSource>                <PMID Version="1">19029405</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Lett. 2004 Aug 20;212(1):83-93</RefSource>                <PMID Version="1">15246564</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <MeshHeadingList>            <MeshHeading>                <DescriptorName UI="D014408" MajorTopicYN="N">Biomarkers, Tumor</DescriptorName>                <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>                <QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName>                <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D002262" MajorTopicYN="N">Carboxy-Lyases</DescriptorName>                <QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D049109" MajorTopicYN="Y">Cell Proliferation</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005434" MajorTopicYN="N">Flow Cytometry</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D015971" MajorTopicYN="N">Gene Expression Regulation, Enzymologic</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D015972" MajorTopicYN="N">Gene Expression Regulation, Neoplastic</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D055785" MajorTopicYN="N">Gene Knockdown Techniques</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D010453" MajorTopicYN="N">Peptide Synthases</DescriptorName>                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>                <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>            </MeshHeading>        </MeshHeadingList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Breast cancer</Keyword>            <Keyword MajorTopicYN="N">Cell apoptosis</Keyword>            <Keyword MajorTopicYN="N">Cell cycle</Keyword>            <Keyword MajorTopicYN="N">PAICS</Keyword>            <Keyword MajorTopicYN="N">Proliferation</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>01</Month>                <Day>09</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>07</Month>                <Day>15</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>8</Month>                <Day>12</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>8</Month>                <Day>12</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>8</Month>                <Day>18</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>epublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30097015</ArticleId>            <ArticleId IdType="doi">10.1186/s40659-018-0172-9</ArticleId>            <ArticleId IdType="pii">10.1186/s40659-018-0172-9</ArticleId>            <ArticleId IdType="pmc">PMC6086025</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>